Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer

مواد مشابهة

• Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcer
  حسب: Jungić Saša, وآخرون
  منشور في: (2017-01-01)
• Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with -mutated metastatic colorectal cancer: the REVOLUTION study protocol
  حسب: Antonio Avallone, وآخرون
  منشور في: (2020-08-01)
• Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
  حسب: Satoru Iwasa, وآخرون
  منشور في: (2023-04-01)
• Retrospective analysis on the clinical efficacy of bevacizumab combined with FOLFOX4 in the first line treatment of metastatic colorectal cancer
  حسب: Eun Mi Lee, وآخرون
  منشور في: (2017-12-01)
• Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
  حسب: Stephen Dyar, وآخرون
  منشور في: (2011-01-01)